Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors
Titel:
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors
Auteur:
Tranchand, Brigitte Catimel, Gilles Lucas, Catherine Sarkany, Marlis Bastian, Gérard Evene, Eric Guastalla, Jean-Paul Négrier, Sylvie Rebattu, Paul Dumortier, Arlette Foy, Maurice Grossin, François Mazier, Béatrice Froudarakis, Marios Barbet, Nicolas Clavel, Michel Ardiet, Claude